STOCHOS THERAPEUTICS

Stochos Therapeutics is a healthcare company.

#SimilarOrganizations #More

STOCHOS THERAPEUTICS

Social Links:

Industry:
Health Care

Address:
Huntsville, Alabama, United States

Country:
United States

Status:
Active


Similar Organizations

oscient-pharmaceuticals-logo

Oscient Pharmaceuticals

Oscient Pharmaceuticals is a health care company.

smartbeauty-logo

SmartBeauty

SmartBeauty is a healthcare company.

More informations about "Stochos Therapeutics"

Stochos Therapeutics - Crunchbase Company Profile & Funding

Stochos Therapeutics is located in Huntsville, Alabama, United States. Who are Stochos Therapeutics 's competitors? Alternatives and possible competitors to Stochos Therapeutics โ€ฆSee details»

Stochos Therapeutics LLC - Drug pipelines, Patents, Clinical trials ...

Last update 19 Sep 2024. Stochos Therapeutics LLC. Private Company |See details»

STOCHOS THERAPEUTICS LLC :: Kentucky (US) - OpenCorporates

Free and open company data on Kentucky (US) company STOCHOS THERAPEUTICS LLC (company number 1011089)See details»

Report Members - AMR Industry Alliance

Allecra Therapeutics, Germany *โ€ Aequor Inc., United States *Agile Sciences, United States ... *Stochos Therapeutics, United States *Summit Therapeutics, โ€ฆSee details»

STOCHOS THERAPEUTICS LLC in Louisville, KY - Bizapedia

STOCHOS THERAPEUTICS LLC is a Kentucky Klc - Limited-Liability Company filed on February 13, 2018. The company's filing status is listed as A - Active and its File Number is 1011089. โ€ฆSee details»

Top 25 Biotech & Medical Jobs companies in โ€ฆ

The HudsonAlpha Institue for Biotechnology is a non-profit organization made up of over 40 companies and growing. The facility is a world-class 270,000 square feet, state-of-the-art laboratory and office, located on a 152 acre campus off โ€ฆSee details»

Stochos Therapeutics - Web 2.0 Directory

Stochos Therapeutics; Address: 601 Genome Way Northwest, Alabama, United States 35806. HudsonAlpha West . Map; directions to: 601 Genome Way Northwest, Alabama, United States โ€ฆSee details»

RE: Growth of Drug-Resistant Fungi Threatens Health in the U.S.

Biotechnology Innovation Organization (BIO) CARB-X Center for Emerging and Neglected Diseases, UC Berkeley Centre to Impact AMR Childrenโ€™s Memorial Hermann Hospital ...See details»

David McClure - Senior Consultant - Crunchbase

Primary Organization . Foresight Science & Technology . Location Huntsville, Alabama, United States; Regions Southern US; Gender Male; LinkedIn View on LinkedIn ; David McClure is a โ€ฆSee details»

KBI Biopharma to Lead Development and Manufacturing of Alanis ...

DURHAM, N.C., December 03, 2024--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), announces โ€ฆSee details»

Emerging Therapeutic Company Investment and Deal Trends - BIO

Emerging Therapeutic Company trends across five areas of investment and deal-making: venture capital, initial public offerings (IPOs), follow-on public offerings, licensing, and acquisitions. โ€ฆSee details»

Capricor unlikely impacted by Phan warning letter, says ... - Nasdaq

2 days ago JonesResearch says shares of Capricor Therapeutics (CAPR) saw some volatility over an FDA warning letter issued to an investigator involved in the deramiocel HOPE-3 study, โ€ฆSee details»

Inside Therapeutics - Crunchbase Company Profile & Funding

Inside Therapeutics offers microfluidic-based systems for nanoparticle manufacturing, focusing on LNP-RNA vaccine development and oncology. Angoulême , Poitou-Charentes , France 11-50See details»

All Three Athos Co-Founders Named to Stanfordโ€™s List of the โ€ฆ

Oct 12, 2023 LOS ANGELES, CA / ACCESSWIRE / October 12, 2023 / Athos Therapeutics, Inc. ("Athos"), a clinical stage biotechnology company pioneering the development of artificial โ€ฆSee details»

Tango Therapeutics Inc. (TNGX): Among the Most Promising โ€ฆ

In its Q3 report, Tango Therapeutics Inc. (NASDAQ:TNGX) announced a solid cash position of $293 million, $11.6 million in collaboration revenue, and a net loss of $29.2 million.See details»

100+ Signatures in Support of Action on Drug-Resistant Fungi

March 15, 2022RE: Growth of Drug-Resistant Fungi Threatens Health in the U.S. Dear Members of Congress and health legislative staff:We write to you out of concern for the growing threat of โ€ฆSee details»

Delix Therapeutics Announces Dosing of First Patient in Phase 1b ...

4 days ago BEDFORD, Mass., December 04, 2024--Delix Therapeutics, a clinical-stage neuroscience company pioneering novel neuroplasticity-promoting treatments for psychiatric โ€ฆSee details»

Three reasons why the STOCHOS AI solution is so well suited to โ€ฆ

Jul 16, 2024 Read the interview with Dr Kevin Cremanns, the developer of STOCHOS, now. Probabilistic machine learning for simulation: With STOCHOS, you always get an indication of โ€ฆSee details»

Stelios Therapeutics - Crunchbase Company Profile & Funding

Stelios Therapeutics is an early-stage company developing novel AAV-based gene therapies for rare genetic cardiac conditions. The company is founded based on research conducted at the โ€ฆSee details»

Stochos: Software for Real-Time Synthesis of Stochastic Music

Stochos: Software for Real-Time Synthesis of Stochastic Music Published in: Computer Music Journal ( Volume: 27 , Issue: 3 , September 2003) Article #: Page(s ... A not-for-profit โ€ฆSee details»

linkstock.net © 2022. All rights reserved